TRANSCRIPTIONAL REGULATION OF TH1/TH2 DIFFERENTIATION

TH1/TH2 分化的转录调控

基本信息

  • 批准号:
    6362459
  • 负责人:
  • 金额:
    $ 11.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-03-15 至 2002-02-28
  • 项目状态:
    已结题

项目摘要

Acquiring the ability to selectively produce interferon gamma (IFNgamma) or interleukin 4 (lL4) is a fundamental property of the immune system and enables T cell subsets (T helper 1, TH1, T helper 2, TH2) to deliver their effector functions. While the accumulated data clearly validate the polarization paradigm, the molecular mechanisms which control differentiation of naive T cells into memory TH1 or TH2 cells are not well understood. Much of what is known about regulation of gene transcription and the activity of individual response elements is derived from studies using immortalized cell lines. Very little is known about the regulation of transcriptional elements in primary cells nor about how transcriptional activity is regulated as primary cells differentiate or respond to external stimuli. This is largely due to the lack of an experimental system which permits investigation of promoter-directed transcriptional activity in primary cells. To address these questions, a novel experimental system will be employed. This system utilizes transgenic mice which express the luciferase gene under the control of a) proximal (prox. b-ZlP[IFNgamma]) and b) distal (dist. b-ZIP[IFNgamma]) response elements from the IFNgamma promoter, which bind b-ZIP transcription factors, c) the -538 to + 64 bp IFNgamma promoter, and d) a response element from the lL4 promoter which binds NF-AT/AP-1 transcription factors. The hypothesis to be tested is that acquisition of memory results from changes in transcriptional activity. The specific aims will focus on a) analyzing changes in transcriptional activity as naive T cells differentiate into effector T cells, b) determining how modulation of gene expression alters transcriptional activity, c) identifying transcription factors required for transcriptional activity, and d) determining if genetic regulation of cytokine production is reflected at the level of transcriptional activity. The long term goals of this project are to understand the molecular events which prevent naive T cells from producing IFNgamma and IL4 and which allow memory T cells to selectively produce these cytokines and to identify the genetic loci which control the development of TH1 or TH2 immunity. In a more general sense, these studies will examine changes in transcriptional activity as cells differentiate in a natural environment and acquire new properties. The immune-based pathology associated with many infectious diseases, including HIV infection, may result from overexpression of lL4 and the pathology associated with autoimmune diseases may result from overexpression of IFNgamma. Understanding regulation of cytokine gene expression may make it possible to correct overexpression of these genes and alleviate pathology associated with these diseases.
获得选择性产生干扰素(IFNgamma)的能力

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation.
  • DOI:
  • 发表时间:
    1998-12
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Feng Zhang;Ding Zhe Wang;M. Boothby;L. Penix;R. A. Flavell;R. A. Flavell;T. Aune
  • 通讯作者:
    Feng Zhang;Ding Zhe Wang;M. Boothby;L. Penix;R. A. Flavell;R. A. Flavell;T. Aune
TCR and IL-12 receptor signals cooperate to activate an individual response element in the IFN-gamma promoter in effector Th cells.
TCR 和 IL-12 受体信号协同激活效应 Th 细胞中 IFN-γ 启动子中的单个反应元件。
Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation.
共刺激可逆转 IL-2 的缺陷,但不能逆转 IkappaBalpha 降解受损的 T 细胞产生效应细胞因子的缺陷。
A minimal IFN-gamma promoter confers Th1 selective expression.
最小的 IFN-gamma 启动子赋予 Th1 选择性表达。
  • DOI:
    10.4049/jimmunol.169.8.4205
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Soutto,Mohammed;Zhang,Feng;Enerson,Ben;Tong,Yingkai;Boothby,Mark;Aune,ThomasM
  • 通讯作者:
    Aune,ThomasM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas M. Aune其他文献

Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
OKT3 引起的人类 T 细胞激活可被 CD44 单克隆抗体抑制。
  • DOI:
    10.4049/jimmunol.147.8.2493
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    B. Rothman;M. Blue;Kevin Kelley;D. Wunderlich;D. Mierz;Thomas M. Aune
  • 通讯作者:
    Thomas M. Aune
Methotrexate and its mechanisms of action in inflammatory arthritis
甲氨蝶呤及其在炎性关节炎中的作用机制
  • DOI:
    10.1038/s41584-020-0373-9
  • 发表时间:
    2020-02-17
  • 期刊:
  • 影响因子:
    32.700
  • 作者:
    Bruce N. Cronstein;Thomas M. Aune
  • 通讯作者:
    Thomas M. Aune
Bromodomain inhibitor JQ1 reversibly blocks IFN-γ production
溴结构域抑制剂 JQ1 可逆性地阻断 IFN-γ 的产生
  • DOI:
    10.1038/s41598-019-46516-x
  • 发表时间:
    2019-07-16
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Hunter R. Gibbons;Deborah J. Mi;Virginia M. Farley;Tashawna Esmond;Mary B. Kaood;Thomas M. Aune
  • 通讯作者:
    Thomas M. Aune

Thomas M. Aune的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas M. Aune', 18)}}的其他基金

Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNA 作为流感疫苗佐剂
  • 批准号:
    10605272
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNA 作为流感疫苗佐剂
  • 批准号:
    10453106
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
A-to-I 编辑缺失会刺激 SARS-CoV-2 抗病毒反应
  • 批准号:
    10353022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
A-to-I 编辑缺失会刺激 SARS-CoV-2 抗病毒反应
  • 批准号:
    10615086
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
LncRNAs tether transcription factors to enable locus-specific regulation and sustain memory T cell phenotype
LncRNA 束缚转录因子以实现位点特异性调节并维持记忆 T 细胞表型
  • 批准号:
    9387202
  • 财政年份:
    2017
  • 资助金额:
    $ 11.61万
  • 项目类别:
Long non-coding RNA signatures to distinguish fibromyalgia syndrome from rheumatic diseases
长非编码 RNA 特征可区分纤维肌痛综合征和风湿性疾病
  • 批准号:
    9555179
  • 财政年份:
    2017
  • 资助金额:
    $ 11.61万
  • 项目类别:
Long non-coding RNA signatures to classify multiple sclerosis
用于对多发性硬化症进行分类的长非编码 RNA 特征
  • 批准号:
    9405679
  • 财政年份:
    2016
  • 资助金额:
    $ 11.61万
  • 项目类别:
Long non-coding RNA signatures to classify multiple sclerosis
用于对多发性硬化症进行分类的长非编码 RNA 特征
  • 批准号:
    9136402
  • 财政年份:
    2016
  • 资助金额:
    $ 11.61万
  • 项目类别:
Cell cycle checkpoint defects lead to chronic inflammation in RA
细胞周期检查点缺陷导致 RA 慢性炎症
  • 批准号:
    8683107
  • 财政年份:
    2013
  • 资助金额:
    $ 11.61万
  • 项目类别:
Cell cycle checkpoint defects lead to chronic inflammation in RA
细胞周期检查点缺陷导致 RA 慢性炎症
  • 批准号:
    8582351
  • 财政年份:
    2013
  • 资助金额:
    $ 11.61万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 11.61万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 11.61万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了